Joint Formulary & PAD

Allergovit (pollen) - Allergen immunotherapy

I agree that in using this database I understand that this platform only provides guidance on local prescribing policy and that all prescribing decisions are ultimately the responsibility of the clinician.

Status 1

Red
Formulations :
  • Subcutaneous injection (sc)
Associated Icons :
R
SPC
Restrictions / Comments :
Important

Allergovit - RSFT Immunology only.

 

Status 2

Red
Formulations :
  • Sub-lingual drops
Associated Icons :
R
SPC
Restrictions / Comments :
Important

Oralvac Compact drops - RSFT Immunology only

 

Status 3

Red
Formulations :
  • Subcutaneous injection (sc)
Associated Icons :
R
SPC
Restrictions / Comments :
Important

Pollinex quattro - RSFT Immunology only

 

Status 4

Red
Formulations :
  • Sublingual tablets
Associated Icons :
R
SPC
Restrictions / Comments :
Important

Lais tablets (grass pollen) - RSFT immunology only

Documentation

  • No records returned.

PAD Profile

ChemicalSubstance :
Allergovit (pollen)
Indication :
Allergen immunotherapy
Group Name :
Keywords :
Pollen allergy
Brand Names Include :
Allergovit, Oralvac Compatc, Pollinex quattro, Lais
Important Information :
Latest Additions Date From :
Latest Additions Date To :
Guidelines :
Supporting Documents :
0
Traffic Light Entries :
4

Other Indications

Below are listed other indications that Allergovit (pollen) is used to treat.

  • No records returned.

Committee Recommendations (1)

The Surrey Heartlands Area Prescribing Committee agreed the traffic light status of this drug and indication as part of the Joint Formulary review.